With so few Alzheimer's drugs available, repurposing medications approved for other conditions could be the key to tackling ...

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

U.S. Food and Drug Administration commissioner Marty Makary has appointed former biotech executive George Tidmarsh as the ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...

Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

The programs don’t do what they claim to. If they were drugs, regulators would pull them from the market.